Weizmann Institute of Science
The Weizmann Institute of Science, located in Rehovot, Israel, is one of the world's leading multidisciplinary research institutions.
The Weizmann School of Science, the Institute's academic arm, is dedicated exclusively to graduate and postgraduate education and scientific discovery, offering MSc and PhD candidates the opportunity to join internationally recognized research groups in biology, chemistry, physics, mathematics, computer science and science education.
Students work closely with faculty mentors in a collaborative, curiosity-driven research environment. Scientists from diverse disciplines work side by side, fostering cross-disciplinary approaches to fundamental and applied scientific questions.
There are no tuition fees, and all graduate students receive a monthly living stipend, allowing them to focus entirely on research. English is the language of instruction, and global collaborations provide international exposure and networking opportunities. Weizmann offers an exceptional scientific home for talented students seeking rigorous training, independence and impact.
Global Recognition
The Weizmann Institute ranks among the world's leading research institutions, ranking 6th globally in the 2025 Leiden Ranking for Research Quality & Impact, and has produced a Nobel Laureate and recipients of international awards.
Scientists made breakthrough contributions in immunology, encryption science and quantum physics, enabling global technologies, therapies and biotech innovations.
Graduates hold leadership roles in academia, industry, education, policy-making and business worldwide.
You may have heard...
Mobileye, co-founded by a Weizmann alumnus, is a global leader in driver-assistance and autonomous driving technology. Acquired by Intel for over $15B and later re-listed, its vision-based systems are now used in millions of vehicles worldwide.
Weizmann research contributed to Copaxone®, a pioneering multiple sclerosis (MS) treatment that became one of the world’s leading MS therapies, generating billions in global sales. It demonstrates translation of fundamental science to medical innovation.